Skip to main content
PMC home page
The Journal of Clinical Investigation logoLink to The Journal of Clinical Investigation
. 1991 Sep;88(3):767–773. doi: 10.1172/JCI115375

Intra-islet insulin permits glucose to directly suppress pancreatic A cell function.

C J Greenbaum 1, P J Havel 1, G J Taborsky Jr 1, L J Klaff 1
PMCID: PMC295460  PMID: 1679440

Abstract

Inhibition of pancreatic glucagon secretion during hyperglycemia could be mediated by (a) glucose, (b) insulin, (c) somatostatin, or (d) glucose in conjunction with insulin. To determine the role of these factors in the mediation of glucagon suppression, we injected alloxan while clamping the arterial supply of the pancreatic splenic lobe of dogs, thus inducing insulin deficiency localized to the ventral lobe and avoiding hyperglycemia. Ventral lobe insulin, glucagon, and somatostatin outputs were then measured in response to a stepped IV glucose infusion. In control dogs glucagon suppression occurred at a glucose level of 150 mg/dl and somatostatin output increased at glucose greater than 250 mg/dl. In alloxan-treated dogs glucagon output was not suppressed nor did somatostatin output increase. We concluded that insulin was required in the mediation of glucagon suppression and somatostatin stimulation. Subsequently, we infused insulin at high rates directly into the artery that supplied the beta cell-deficient lobe in six alloxan-treated dogs. Insulin infusion alone did not cause suppression of glucagon or stimulation of somatostatin; however, insulin repletion during glucose infusions did restore the ability of hyperglycemia to suppress glucagon and stimulate somatostatin. We conclude that intra-islet insulin permits glucose to suppress glucagon secretion and stimulate somatostatin during hyperglycemia.

Full text

PDF
767

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Bolli G., De Feo P., Perriello G., De Cosmo S., Compagnucci P., Santeusanio F., Brunetti P., Unger R. H. Mechanisms of glucagon secretion during insulin-induced hypoglycemia in man. Role of the beta cell and arterial hyperinsulinemia. J Clin Invest. 1984 Apr;73(4):917–922. doi: 10.1172/JCI111315. [DOI] [PMC free article] [PubMed] [Google Scholar]
  2. Bonner-Weir S., Orci L. New perspectives on the microvasculature of the islets of Langerhans in the rat. Diabetes. 1982 Oct;31(10):883–889. doi: 10.2337/diab.31.10.883. [DOI] [PubMed] [Google Scholar]
  3. Braaten J. T., Faloona G. R., Unger R. H. The effect of insulin on the alpha-cell response to hyperglycemia in long-standing alloxan diabetes. J Clin Invest. 1974 Apr;53(4):1017–1021. doi: 10.1172/JCI107638. [DOI] [PMC free article] [PubMed] [Google Scholar]
  4. Buchanan K. D., Mawhinney W. A. Glucagon release from isolated pancreas in streptozotocin-treated rats. Diabetes. 1973 Nov;22(11):797–800. doi: 10.2337/diab.22.11.797. [DOI] [PubMed] [Google Scholar]
  5. Buchanan K. D., Mawhinney W. A. Insulin control of glucagon release from insulin-deficient rat islets. Diabetes. 1973 Nov;22(11):801–803. doi: 10.2337/diab.22.11.801. [DOI] [PubMed] [Google Scholar]
  6. Chen L., Komiya I., Inman L., McCorkle K., Alam T., Unger R. H. Molecular and cellular responses of islets during perturbations of glucose homeostasis determined by in situ hybridization histochemistry. Proc Natl Acad Sci U S A. 1989 Feb;86(4):1367–1371. doi: 10.1073/pnas.86.4.1367. [DOI] [PMC free article] [PubMed] [Google Scholar]
  7. Ensinck J. W., Shepard C., Dudl R. J., Williams R. H. Use of benzamidine as a proteolytic inhibitor in the radioimmunoassay of glucagon in plasma. J Clin Endocrinol Metab. 1972 Sep;35(3):463–467. doi: 10.1210/jcem-35-3-463. [DOI] [PubMed] [Google Scholar]
  8. Filipponi P., Gregorio F., Cristallini S., Ferrandina C., Nicoletti I., Santeusanio F. Selective impairment of pancreatic A cell suppression by glucose during acute alloxan-induced insulinopenia: in vitro study on isolated perfused rat pancreas. Endocrinology. 1986 Jul;119(1):408–415. doi: 10.1210/endo-119-1-408. [DOI] [PubMed] [Google Scholar]
  9. Fujimoto W. Y., Ensinck J. W. Regulation of A- and B-cell function by insulin and glucagon. Horm Metab Res. 1981 Oct;13(10):547–550. doi: 10.1055/s-2007-1019331. [DOI] [PubMed] [Google Scholar]
  10. Gersell D. J., Gingerich R. L., Greider M. H. Regional distribution and concentration of pancreatic polypeptide in the human and canine pancreas. Diabetes. 1979 Jan;28(1):11–15. [PubMed] [Google Scholar]
  11. Gingerich R. L., Lacy P. E., Chance R. E., Johnson M. G. Regional pancreatic concentration and in-vitro secretion of canine pancreatic polypeptide, insulin, and glucagon. Diabetes. 1978 Feb;27(2):96–101. doi: 10.2337/diab.27.2.96. [DOI] [PubMed] [Google Scholar]
  12. Havel P. J., Veith R. C., Dunning B. E., Taborsky G. J., Jr Pancreatic noradrenergic nerves are activated by neuroglucopenia but not by hypotension or hypoxia in the dog. Evidence for stress-specific and regionally selective activation of the sympathetic nervous system. J Clin Invest. 1988 Nov;82(5):1538–1545. doi: 10.1172/JCI113763. [DOI] [PMC free article] [PubMed] [Google Scholar]
  13. Hermansen K., Orskov H., Christensen S. E. Streptozotocin diabetes: a glucoreceptor dysfunction affecting D cells as well as B and A cells. Diabetologia. 1979 Dec;17(6):385–389. doi: 10.1007/BF01236274. [DOI] [PubMed] [Google Scholar]
  14. Hisatomi A., Maruyama H., Orci L., Vasko M., Unger R. H. Adrenergically mediated intrapancreatic control of the glucagon response to glucopenia in the isolated rat pancreas. J Clin Invest. 1985 Feb;75(2):420–426. doi: 10.1172/JCI111716. [DOI] [PMC free article] [PubMed] [Google Scholar]
  15. Imamura T., Koffler M., Helderman J. H., Prince D., Thirlby R., Inman L., Unger R. H. Severe diabetes induced in subtotally depancreatized dogs by sustained hyperglycemia. Diabetes. 1988 May;37(5):600–609. doi: 10.2337/diab.37.5.600. [DOI] [PubMed] [Google Scholar]
  16. Kaestner K. H., Christy R. J., McLenithan J. C., Braiterman L. T., Cornelius P., Pekala P. H., Lane M. D. Sequence, tissue distribution, and differential expression of mRNA for a putative insulin-responsive glucose transporter in mouse 3T3-L1 adipocytes. Proc Natl Acad Sci U S A. 1989 May;86(9):3150–3154. doi: 10.1073/pnas.86.9.3150. [DOI] [PMC free article] [PubMed] [Google Scholar]
  17. Klaff L. J., Taborsky G. J., Jr Pancreatic somatostatin is a mediator of glucagon inhibition by hyperglycemia. Diabetes. 1987 May;36(5):592–596. doi: 10.2337/diab.36.5.592. [DOI] [PubMed] [Google Scholar]
  18. Leahy J. L., Bonner-Weir S., Weir G. C. Abnormal glucose regulation of insulin secretion in models of reduced B-cell mass. Diabetes. 1984 Jul;33(7):667–673. doi: 10.2337/diab.33.7.667. [DOI] [PubMed] [Google Scholar]
  19. Leahy J. L., Bonner-Weir S., Weir G. C. Abnormal insulin secretion in a streptozocin model of diabetes. Effects of insulin treatment. Diabetes. 1985 Jul;34(7):660–666. doi: 10.2337/diab.34.7.660. [DOI] [PubMed] [Google Scholar]
  20. Leahy J. L., Bonner-Weir S., Weir G. C. Minimal chronic hyperglycemia is a critical determinant of impaired insulin secretion after an incomplete pancreatectomy. J Clin Invest. 1988 May;81(5):1407–1414. doi: 10.1172/JCI113470. [DOI] [PMC free article] [PubMed] [Google Scholar]
  21. Lenzen S., Panten U. Alloxan: history and mechanism of action. Diabetologia. 1988 Jun;31(6):337–342. doi: 10.1007/BF02341500. [DOI] [PubMed] [Google Scholar]
  22. Maruyama H., Hisatomi A., Orci L., Grodsky G. M., Unger R. H. Insulin within islets is a physiologic glucagon release inhibitor. J Clin Invest. 1984 Dec;74(6):2296–2299. doi: 10.1172/JCI111658. [DOI] [PMC free article] [PubMed] [Google Scholar]
  23. Müller W. A., Faloona G. R., Unger R. H. The effect of experimental insulin deficiency on glucagon secretion. J Clin Invest. 1971 Sep;50(9):1992–1999. doi: 10.1172/JCI106691. [DOI] [PMC free article] [PubMed] [Google Scholar]
  24. Patel Y. C., Amherdt M., Orci L. Somatostatin secretion from monolayer cultures of neonatal rat pancreas. Endocrinology. 1979 Mar;104(3):676–679. doi: 10.1210/endo-104-3-676. [DOI] [PubMed] [Google Scholar]
  25. Pipeleers D. G., Schuit F. C., Van Schravendijk C. F., Van de Winkel M. Interplay of nutrients and hormones in the regulation of glucagon release. Endocrinology. 1985 Sep;117(3):817–823. doi: 10.1210/endo-117-3-817. [DOI] [PubMed] [Google Scholar]
  26. Rerup C. C. Drugs producing diabetes through damage of the insulin secreting cells. Pharmacol Rev. 1970 Dec;22(4):485–518. [PubMed] [Google Scholar]
  27. Rossetti L., Shulman G. I., Zawalich W., DeFronzo R. A. Effect of chronic hyperglycemia on in vivo insulin secretion in partially pancreatectomized rats. J Clin Invest. 1987 Oct;80(4):1037–1044. doi: 10.1172/JCI113157. [DOI] [PMC free article] [PubMed] [Google Scholar]
  28. Samols E., Bonner-Weir S., Weir G. C. Intra-islet insulin-glucagon-somatostatin relationships. Clin Endocrinol Metab. 1986 Feb;15(1):33–58. doi: 10.1016/s0300-595x(86)80041-x. [DOI] [PubMed] [Google Scholar]
  29. Samols E., Stagner J. I., Ewart R. B., Marks V. The order of islet microvascular cellular perfusion is B----A----D in the perfused rat pancreas. J Clin Invest. 1988 Jul;82(1):350–353. doi: 10.1172/JCI113593. [DOI] [PMC free article] [PubMed] [Google Scholar]
  30. Sorenson R. L., Elde R. P. Dissociation of glucose stimulation of somatostatin and insulin release from glucose inhibition of glucagon release in the isolated perfused rat pancreas. Diabetes. 1983 Jun;32(6):561–567. doi: 10.2337/diab.32.6.561. [DOI] [PubMed] [Google Scholar]
  31. Stagner J. I., Samols E., Bonner-Weir S. beta----alpha----delta pancreatic islet cellular perfusion in dogs. Diabetes. 1988 Dec;37(12):1715–1721. doi: 10.2337/diab.37.12.1715. [DOI] [PubMed] [Google Scholar]
  32. Stagner J. I., Samols E. Retrograde perfusion as a model for testing the relative effects of glucose versus insulin on the A cell. J Clin Invest. 1986 Mar;77(3):1034–1037. doi: 10.1172/JCI112356. [DOI] [PMC free article] [PubMed] [Google Scholar]
  33. Starke A., Grundy S., McGarry J. D., Unger R. H. Correction of hyperglycemia with phloridzin restores the glucagon response to glucose in insulin-deficient dogs: implications for human diabetes. Proc Natl Acad Sci U S A. 1985 Mar;82(5):1544–1546. doi: 10.1073/pnas.82.5.1544. [DOI] [PMC free article] [PubMed] [Google Scholar]
  34. Starke A., Imamura T., Unger R. H. Relationship of glucagon suppression by insulin and somatostatin to the ambient glucose concentration. J Clin Invest. 1987 Jan;79(1):20–24. doi: 10.1172/JCI112784. [DOI] [PMC free article] [PubMed] [Google Scholar]
  35. Taborsky G. J., Jr Evidence of a paracrine role for pancreatic somatostatin in vivo. Am J Physiol. 1983 Dec;245(6):E598–E603. doi: 10.1152/ajpendo.1983.245.6.E598. [DOI] [PubMed] [Google Scholar]
  36. Trimble E. R., Gerber P. P., Renold A. E. Abnormalities of pancreatic somatostatin secretion corrected by in vivo insulin treatment of streptozotocin-diabetic rats. Diabetes. 1981 Oct;30(10):865–867. doi: 10.2337/diab.30.10.865. [DOI] [PubMed] [Google Scholar]
  37. Unger R. H. Glucagon physiology and pathophysiology in the light of new advances. Diabetologia. 1985 Aug;28(8):574–578. doi: 10.1007/BF00281991. [DOI] [PubMed] [Google Scholar]
  38. Unger R. H., Grundy S. Hyperglycaemia as an inducer as well as a consequence of impaired islet cell function and insulin resistance: implications for the management of diabetes. Diabetologia. 1985 Mar;28(3):119–121. doi: 10.1007/BF00273856. [DOI] [PubMed] [Google Scholar]
  39. Weir G. C., Knowlton S. D., Martin D. B. Glucagon secretion from the perfused rat pancreas. Studies with glucose and catecholamines. J Clin Invest. 1974 Dec;54(6):1403–1412. doi: 10.1172/JCI107887. [DOI] [PMC free article] [PubMed] [Google Scholar]
  40. Weir G. C., Samols E., Loo S., Patel Y. C., Gabbay K. H. Somatostatin and pancreatic polypeptide secretion: effects of glucagon, insulin, and arginine. Diabetes. 1979 Jan;28(1):35–40. [PubMed] [Google Scholar]
  41. de Haën C., Little S. A., May J. M., Williams R. H. Characterization of proinsulin-insulin intermediates in human plasma. J Clin Invest. 1978 Oct;62(4):727–737. doi: 10.1172/JCI109183. [DOI] [PMC free article] [PubMed] [Google Scholar]

Articles from Journal of Clinical Investigation are provided here courtesy of American Society for Clinical Investigation

RESOURCES